Cangemi, G., Barco, S., Verrina, E.E., Scurati, S., Melioli, G. and Della Casa Alberighi, O. (2013) Micromethod for Quantification of Cinacalcet in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Using a Stable Isotope-Labeled Internal Standard. Therapeutic Drug Monitoring, 35, 112-117.
https://doi.org/10.1097/FTD.0b013e318278dc69

has been cited by the following article:

• TITLE: Determination and Validation of HPTLC Method for Cinacalcet Hydrochloride

  AUTHORS: Swetha Kamatham, Ciddi Veeresham

  KEYWORDS: Cinacalcet Hydrochloride, HPTLC, Method Validation, Densitometry, Forced Degradation

  JOURNAL NAME: American Journal of Analytical Chemistry, Vol.10 No.2, February 11, 2019

  ABSTRACT: Cinacalcet Hydrochloride (CIN) is a new calcimimetic agent indicated for the use in hypercalcemia. The present work is aimed at development and validation of a novel and simple high-performance thin-layer chromatographic (HPTLC) method for the analysis of Cinacalcet Hydrochloride (active pharmaceutical ingredient, API. In the method, Aluminum-backed silica gel 60 F254 plates (10 × 10 cm) were used as stationary phase and chloroform: acetonitrile (6:4, v/v) as the mobile phase, which showed compact bands of Cinacalcet HCl (RF 0.30 ± 0.02). Quantitative analysis was carried out by densitometry at a wavelength of 282 nm. Linear regression analysis for the calibration spots showed good correlation ship with regression co-efficient r2 = 0.9994 in the range of 40 - 160 ng/band. The developed method suitability for quantification of CIN was learned by validating it as per the ICH guidelines. CIN detection limit was 0.48 ng/band and the quantification limit was 1.59 ng/band. The proposed method was found to be linear (r2 = 0.999), precise (%RSD